These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28584075)

  • 1. Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial.
    Forlenza GP; Deshpande S; Ly TT; Howsmon DP; Cameron F; Baysal N; Mauritzen E; Marcal T; Towers L; Bequette BW; Huyett LM; Pinsker JE; Gondhalekar R; Doyle FJ; Maahs DM; Buckingham BA; Dassau E
    Diabetes Care; 2017 Aug; 40(8):1096-1102. PubMed ID: 28584075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial.
    Kropff J; Del Favero S; Place J; Toffanin C; Visentin R; Monaro M; Messori M; Di Palma F; Lanzola G; Farret A; Boscari F; Galasso S; Magni P; Avogaro A; Keith-Hynes P; Kovatchev BP; Bruttomesso D; Cobelli C; DeVries JH; Renard E; Magni L;
    Lancet Diabetes Endocrinol; 2015 Dec; 3(12):939-47. PubMed ID: 26432775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Day-and-Night Closed-Loop Glucose Control in Patients With Type 1 Diabetes Under Free-Living Conditions: Results of a Single-Arm 1-Month Experience Compared With a Previously Reported Feasibility Study of Evening and Night at Home.
    Renard E; Farret A; Kropff J; Bruttomesso D; Messori M; Place J; Visentin R; Calore R; Toffanin C; Di Palma F; Lanzola G; Magni P; Boscari F; Galasso S; Avogaro A; Keith-Hynes P; Kovatchev B; Del Favero S; Cobelli C; Magni L; DeVries JH;
    Diabetes Care; 2016 Jul; 39(7):1151-60. PubMed ID: 27208331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycemia, Treatment Satisfaction, Cognition, and Sleep Quality in Adults and Adolescents with Type 1 Diabetes When Using a Closed-Loop System Overnight Versus Sensor-Augmented Pump with Low-Glucose Suspend Function: A Randomized Crossover Study.
    Sharifi A; De Bock MI; Jayawardene D; Loh MM; Horsburgh JC; Berthold CL; Paramalingam N; Bach LA; Colman PG; Davis EA; Grosman B; Hendrieckx C; Jenkins AJ; Kumareswaran K; Kurtz N; Kyoong A; MacIsaac RJ; Speight J; Trawley S; Ward GM; Roy A; Jones TW; O'Neal DN
    Diabetes Technol Ther; 2016 Dec; 18(12):772-783. PubMed ID: 27835037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability.
    Anderson SM; Dassau E; Raghinaru D; Lum J; Brown SA; Pinsker JE; Church MM; Levy C; Lam D; Kudva YC; Buckingham B; Forlenza GP; Wadwa RP; Laffel L; Doyle FJ; DeVries JH; Renard E; Cobelli C; Boscari F; Del Favero S; Kovatchev BP
    Diabetes Technol Ther; 2019 Feb; 21(2):73-80. PubMed ID: 30649925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DREAM5: An open-label, randomized, cross-over study to evaluate the safety and efficacy of day and night closed-loop control by comparing the MD-Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at home.
    Biester T; Nir J; Remus K; Farfel A; Muller I; Biester S; Atlas E; Dovc K; Bratina N; Kordonouri O; Battelino T; Philip M; Danne T; Nimri R
    Diabetes Obes Metab; 2019 Apr; 21(4):822-828. PubMed ID: 30478937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and Clinical Evaluation of the Interoperable Artificial Pancreas System (iAPS) Smartphone App: Interoperable Components with Modular Design for Progressive Artificial Pancreas Research and Development.
    Deshpande S; Pinsker JE; Zavitsanou S; Shi D; Tompot R; Church MM; Andre C; Doyle FJ; Dassau E
    Diabetes Technol Ther; 2019 Jan; 21(1):35-43. PubMed ID: 30547670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overnight Closed-Loop Control Improves Glycemic Control in a Multicenter Study of Adults With Type 1 Diabetes.
    Brown SA; Breton MD; Anderson SM; Kollar L; Keith-Hynes P; Levy CJ; Lam DW; Levister C; Baysal N; Kudva YC; Basu A; Dadlani V; Hinshaw L; McCrady-Spitzer S; Bruttomesso D; Visentin R; Galasso S; Del Favero S; Leal Y; Boscari F; Avogaro A; Cobelli C; Kovatchev BP
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3674-3682. PubMed ID: 28666360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.
    Russell SJ; Hillard MA; Balliro C; Magyar KL; Selagamsetty R; Sinha M; Grennan K; Mondesir D; Ekhlaspour L; Zheng H; Damiano ER; El-Khatib FH
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):233-243. PubMed ID: 26850709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraperitoneal insulin delivery provides superior glycaemic regulation to subcutaneous insulin delivery in model predictive control-based fully-automated artificial pancreas in patients with type 1 diabetes: a pilot study.
    Dassau E; Renard E; Place J; Farret A; Pelletier MJ; Lee J; Huyett LM; Chakrabarty A; Doyle FJ; Zisser HC
    Diabetes Obes Metab; 2017 Dec; 19(12):1698-1705. PubMed ID: 28474383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized Summer Camp Crossover Trial in 5- to 9-Year-Old Children: Outpatient Wearable Artificial Pancreas Is Feasible and Safe.
    Del Favero S; Boscari F; Messori M; Rabbone I; Bonfanti R; Sabbion A; Iafusco D; Schiaffini R; Visentin R; Calore R; Moncada YL; Galasso S; Galderisi A; Vallone V; Di Palma F; Losiouk E; Lanzola G; Tinti D; Rigamonti A; Marigliano M; Zanfardino A; Rapini N; Avogaro A; Chernavvsky D; Magni L; Cobelli C; Bruttomesso D
    Diabetes Care; 2016 Jul; 39(7):1180-5. PubMed ID: 27208335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybrid Closed Loop Using a Do-It-Yourself Artificial Pancreas System in Adults With Type 1 Diabetes.
    Nanayakkara N; Sharifi A; Burren D; Elghattis Y; Jayarathna DK; Cohen N
    J Diabetes Sci Technol; 2024 Jul; 18(4):889-896. PubMed ID: 36788715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient Randomized Crossover Comparison of Zone Model Predictive Control Automated Insulin Delivery with Weekly Data Driven Adaptation Versus Sensor-Augmented Pump: Results from the International Diabetes Closed-Loop Trial 4.
    Pinsker JE; Dassau E; Deshpande S; Raghinaru D; Buckingham BA; Kudva YC; Laffel LM; Levy CJ; Church MM; Desrochers H; Ekhlaspour L; Kaur RJ; Levister C; Shi D; Lum JW; Kollman C; Doyle FJ;
    Diabetes Technol Ther; 2022 Sep; 24(9):635-642. PubMed ID: 35549708
    [No Abstract]   [Full Text] [Related]  

  • 14. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.
    Clarke WL; Anderson S; Breton M; Patek S; Kashmer L; Kovatchev B
    J Diabetes Sci Technol; 2009 Sep; 3(5):1031-8. PubMed ID: 20144416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fully Closed Loop Glucose Control With a Bihormonal Artificial Pancreas in Adults With Type 1 Diabetes: An Outpatient, Randomized, Crossover Trial.
    Blauw H; Onvlee AJ; Klaassen M; van Bon AC; DeVries JH
    Diabetes Care; 2021 Mar; 44(3):836-838. PubMed ID: 33397767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outpatient Randomized Crossover Automated Insulin Delivery Versus Conventional Therapy with Induced Stress Challenges.
    Kaur RJ; Deshpande S; Pinsker JE; Gilliam WP; McCrady-Spitzer S; Zaniletti I; Desjardins D; Church MM; Doyle Iii FJ; Kremers WK; Dassau E; Kudva YC
    Diabetes Technol Ther; 2022 May; 24(5):338-349. PubMed ID: 35049354
    [No Abstract]   [Full Text] [Related]  

  • 17. First use of model predictive control in outpatient wearable artificial pancreas.
    Del Favero S; Bruttomesso D; Di Palma F; Lanzola G; Visentin R; Filippi A; Scotton R; Toffanin C; Messori M; Scarpellini S; Keith-Hynes P; Kovatchev BP; Devries JH; Renard E; Magni L; Avogaro A; Cobelli C;
    Diabetes Care; 2014; 37(5):1212-5. PubMed ID: 24757228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Night glucose control with MD-Logic artificial pancreas in home setting: a single blind, randomized crossover trial-interim analysis.
    Nimri R; Muller I; Atlas E; Miller S; Kordonouri O; Bratina N; Tsioli C; Stefanija MA; Danne T; Battelino T; Phillip M
    Pediatr Diabetes; 2014 Mar; 15(2):91-9. PubMed ID: 23944875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multinational Home Use of Closed-Loop Control Is Safe and Effective.
    Anderson SM; Raghinaru D; Pinsker JE; Boscari F; Renard E; Buckingham BA; Nimri R; Doyle FJ; Brown SA; Keith-Hynes P; Breton MD; Chernavvsky D; Bevier WC; Bradley PK; Bruttomesso D; Del Favero S; Calore R; Cobelli C; Avogaro A; Farret A; Place J; Ly TT; Shanmugham S; Phillip M; Dassau E; Dasanayake IS; Kollman C; Lum JW; Beck RW; Kovatchev B;
    Diabetes Care; 2016 Jul; 39(7):1143-50. PubMed ID: 27208316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of an Artificial Pancreas with Enhanced Model Predictive Control and a Glucose Prediction Trust Index with Unannounced Exercise.
    Pinsker JE; Laguna Sanz AJ; Lee JB; Church MM; Andre C; Lindsey LE; Doyle FJ; Dassau E
    Diabetes Technol Ther; 2018 Jul; 20(7):455-464. PubMed ID: 29958023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.